New Delhi, 28 Mar, 2015: B Jain Pharmaceuticals, the leading manufacturer and marketer of homeopathic medicines have introduced its latest product, Omeo Calendula, an antiseptic spray to treat wound.The product is available at all leading homeopathic shops in India.
Omeo Calendula Spray is an antiseptic medicine that heals Abrasion,wounds, Carbuncles and Surgical Cuts quickly. It prevents suppuration and favors phagocytosis. The homeopathic antiseptic is rolled out in 30ml sprayers.
With a turnover of over 12 crores, the company is a leading exporter of homeopathic medicines. It has been exporting medicines to more than 18 countries across the globe. It is the only homeopathic company to have two GMP Certifications in India and Canada.
B Jain is poised to be a leading player in homeopathic sector of the nation. Being more than 45 years in the market, it craters to a diverse need of the industry;publishing journals, books and magazines. In addition, it manufactures products such as globules and remedy bags along with medicines. It is noteworthy that in 2010, it was the first pharmaceutical company in Asia to invest in development and procurement of K-Tronic, a strong homeopathic potentiser.
MR.NISHANT JAIN, DIRECTOR OF B JAIN PHARMACEUTICALS SAYS, “Our products are gaining good response in the Market. Omeo Calendula will soon be a leading antiseptic in the medical Industry
. I believe our consistent quality in manufacturing has been the sole reason of our survival. We are observing a new optimistic surge in the market for homeopathy.”CCI Newswire
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…